Eli Lilly & Co. (NYSE:LLY) reported Q1 EPS of $2.62, $0.49 better than the analyst estimate of $2.13. Revenue for the quarter came in at $7.81 billion versus the consensus estimate of $6.68 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2022 EPS of $8.15-$8.30, versus the consensus of $8.19.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.